CoChat
Sign Up
Cited by 16

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Vimentin Regulates Neuroplasticity in Transected Spinal Cord Rats Associated with micRNA138

Qian, Bao-Jiang, You, Ling, Shang, Fei-Fei, Liu, Jia, Dai, Ping, Lin, Na, He, Mu, Liu, Ran, Zhang, Yuan, Xu, Yang, Zhang, Yun-Hui, Wang, Ting-Hua·2015·Molecular Neurobiology
DOI 10.1007/s12035-014-8745-2
Open this paper in CoChat — free account

Abstract

Spinal cord injury (SCI) often results in motor disability concomitant with limit neuroplasticity; the underlying mechanism, however, is still unclear. This study established spinal cord transection rats model (T10), then performed cDNA microarray analysis and found that vimentin located in astrocytes was increased significantly in scar tissues after transection. To understand the role of vimentin and it's mechanism of regulation, RNA interference and luciferase assay were used. Vimentin knockdown in the scar tissues showed a significant improvement on locomotor function in hindlimbs, while vimentin overexpression exhibited an opposite effect. In vitro, vimentin downregulation or overexpression can effectively inhibit or increase astrogliosis, respectively. Moreover, by using biological informatics technology, we predicted that vimentin may be as the target of micRNA138 (miR-138), and confirmed that miR-138 could regulate vimentin by luciferase activity assay. The present results not only validated the exact role of vimentin in transected spinal cord, but also exhibited a novel regulation mechanism, in which miR-138 may regulate vimentin to promote neuroplasticity. It, therefore, provides a novel target for gene drug discovery based on miRNA-138 or vimentin for the treatment of SCI in the future clinic trial.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12035-014-8745-2

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 46

  1. Cui X, Chen L, Ren Y, Ji Y, Liu W, Liu J, Yan Q, Cheng L, Sun YE (2013) Genetic modification of mesenchymal stem cells in spinal cord injury repair strategies. Biosci Trends 7:202–208
  2. Rowland JW, Hawryluk GW, Kwon B, Fehlings MG (2008) Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon. Neurosurg Focus 25:E2. doi: 10.3171/foc.2008.25.11.e2 · DOI
  3. Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5:146–156. doi: 10.1038/nrn1326 · DOI
  4. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69. doi: 10.1038/nrn2038 · DOI · Paper page
  5. Shechter R, Raposo C, London A, Sagi I, Schwartz M (2011) The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair. PLoS One 6:e27969. doi: 10.1371/journal.pone.0027969 · DOI
  6. Frisen J, Haegerstrand A, Risling M, Fried K, Johansson CB, Hammarberg H, Elde R, Hokfelt T, Cullheim S (1995) Spinal axons in central nervous system scar tissue are closely related to laminin-immunoreactive astrocytes. Neuroscience 65:293–304 · DOI
  7. Lin B, Xu Y, Zhang B, He Y, Yan Y, He MC (2014) MEK inhibition reduces glial scar formation and promotes the recovery of sensorimotor function in rats following spinal cord injury. Exp Ther Med 7:66–72. doi: 10.3892/etm.2013.1371 · DOI
  8. Satelli A, Li S (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68:3033–3046. doi: 10.1007/s00018-011-0735-1 · DOI
  9. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114. doi: 10.1038/nrg2290 · DOI
  10. Bonauer A, Dimmeler S (2009) The microRNA-17-92 cluster: Still a miracle? Cell Cycle 8:3866–3873 · DOI
  11. Fang L, Du WW, Yang W, Rutnam ZJ, Peng C, Li H, O’Malley YQ, Askeland RW, Sugg S, Liu M, Mehta T, Deng Z, Yang BB (2012) MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 11:4352–4365. doi: 10.4161/cc.22670 · DOI
  12. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G, Chartrand P (2007) An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282:2135–2143. doi: 10.1074/jbc.M608939200 · DOI
  13. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890–902 · DOI
  14. Basso DM, Beattie MS, Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1–21 · DOI · Paper page
  15. Guo X, Liu W, Pan Y, Ni P, Ji J, Guo L, Zhang J, Wu J, Jiang J, Chen X, Cai Q, Li J, Zhang J, Gu Q, Liu B, Zhu Z, Yu Y (2010) Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene 29:3908–3920. doi: 10.1038/onc.2010.143 · DOI
  16. Blits B, Kitay BM, Farahvar A, Caperton CV, Dietrich WD, Bunge MB (2005) Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue. Restor Neurol Neurosci 23:313–324
  17. Low K, Blesch A, Herrmann J, Tuszynski MH (2010) A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury. Gene Ther 17:577–591. doi: 10.1038/gt.2010.14 · DOI
  18. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M (2007) The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 82:95–111. doi: 10.1016/s0074-7742(07)82005-8 · DOI
  19. Raginov IS, Chelyshev Iu A, Shagidullin TF (2002) Interaction of sensory neurons and satellite cells during stimulation of the nerve regeneration. Morfologiia 122:37–39
  20. Wang X, Messing A, David S (1997) Axonal and nonneuronal cell responses to spinal cord injury in mice lacking glial fibrillary acidic protein. Exp Neurol 148:568–576. doi: 10.1006/exnr.1997.6702 · DOI
  21. Xiao L, Ma ZL, Li X, Lin QX, Que HP, Liu SJ (2005) cDNA microarray analysis of spinal cord injury and regeneration related genes in rat. Sheng Li Xue Bao 57:705–713
  22. Menet V, Gimenez YRM, Sandillon F, Privat A (2000) GFAP null astrocytes are a favorable substrate for neuronal survival and neurite growth. Glia 31:267–272 · DOI
  23. Menet V, Gimenez Y, Ribotta MChauvet N, Drian MJ, Lannoy J, Colucci-Guyon E, Privat A (2001) Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J Neurosci 21:6147–6158 · DOI
  24. Gimenez Y, Ribotta M, Rajaofetra N, Morin-Richaud C, Alonso G, Bochelen D, Sandillon F, Legrand A, Mersel M, Privat A (1995) Oxysterol (7 beta-hydroxycholesteryl-3-oleate) promotes serotonergic reinnervation in the lesioned rat spinal cord by reducing glial reaction. J Neurosci Res 41:79–95. doi: 10.1002/jnr.490410110 · DOI
  25. Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH, Frisen J (1999) Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 145:503–514 · DOI · Paper page
  26. Wang C, Li Q (2007) Identification of differentially expressed microRNAs during the development of Chinese murine mammary gland. J Genet Genomics 34:966–973. doi: 10.1016/s1673-8527(07)60109-x · DOI
  27. Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M, Khudayberdiev S, Leuschner PF, Busch CJ, Kane C, Hubel K, Dekker F, Hedberg C, Rengarajan B, Drepper C, Waldmann H, Kauppinen S, Greenberg ME, Draguhn A, Rehmsmeier M, Martinez J, Schratt GM (2009) A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 11:705–716. doi: 10.1038/ncb1876 · DOI · Paper page
  28. Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D (2008) microRNA-138 modulates cardiac patterning during embryonic development. Proc Natl Acad Sci U S A 105:17830–17835. doi: 10.1073/pnas.0804673105 · DOI
  29. Kisliouk T, Yosefi S, Meiri N (2011) MiR-138 inhibits EZH2 methyltransferase expression and methylation of histone H3 at lysine 27, and affects thermotolerance acquisition. Eur J Neurosci 33:224–235. doi: 10.1111/j.1460-9568.2010.07493.x · DOI
  30. Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu H, Ikeda K, Wakabayashi G, Masuda T (2008) Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 99:280–286. doi: 10.1111/j.1349-7006.2007.00666.x · DOI
  31. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC (2009) MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 106:12085–12090. doi: 10.1073/pnas.0905234106 · DOI · Paper page
  32. Zhao X, Yang L, Hu J, Ruan J (2010) miR-138 might reverse multidrug resistance of leukemia cells. Leuk Res 34:1078–1082. doi: 10.1016/j.leukres.2009.10.002 · DOI · Paper page
  33. Liu X, Jiang L, Wang A, Yu J, Shi F, Zhou X (2009) MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 286:217–222. doi: 10.1016/j.canlet.2009.05.030 · DOI
  34. Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE, Shi F, Zhou X (2010) Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 127:505–512. doi: 10.1002/ijc.25320 · DOI
  35. Liang J, Zhang Y, Jiang G, Liu Z, Xiang W, Chen X, Chen Z, Zhao J (2014) MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma. Oncol Res Featuring Preclin Clin Cancer Ther 21:83–91. doi: 10.3727/096504013X13775486749218 · DOI
  36. Ye X, Yu H, Jin Y, Jing X, Xu M, Wan Z, Zhang X (2014) miR‐138 inhibits proliferation by targeting 3‐phosphoinositide‐dependent protein kinase‐1 in non‐small cell lung cancer cells. Clin Respir J. doi: 10.1111/crj.12100 · DOI
  37. Sen A, Ren S, Lerchenmüller C, Sun J, Weiss N, Most P, Peppel K (2013) MicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting s100a1. PLoS One 8:e78684. doi: 10.1371/journal · DOI
  38. Long L, Huang G, Zhu H, Guo Y, Liu Y, Huo J (2013) Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. J Transl Med 11:275. doi: 10.1186/1479-5876-11-275 · DOI
  39. He S, Liu P, Jian Z, Li J, Zhu Y, Feng Z, Xiao Y (2013) miR-138 protects cardiomyocytes from hypoxia-induced apoptosis via MLK3/JNK/c-jun pathway. Biochem Biophys Res Commun 441:763–769. doi: 10.1016/j.bbrc.2013.10.151 · DOI
  40. Li J, Chen Y, Qin X, Wen J, Ding H, Xia W, Li S, Su X, Wang W, Li H (2014) MiR-138 downregulates miRNA processing in HeLa cells by targeting RMND5A and decreasing Exportin-5 stability. Nucleic Acids Res 42:458–474. doi: 10.1093/nar/gkt839 · DOI
  41. Shanshan L, Yajuan R, Dandan Z, Jianguo C, Shuzhen L, Daling Z (2013) MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1. Biochem J 452:281–291. doi: 10.1042/BJ20120680 · DOI
  42. Wang Q, Tang H, Yin S, Dong C (2013) Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9. Oncol Rep 29:2046–2052. doi: 10.3892/or.2013.2304 · DOI
  43. Kisliouk T, Meiri N (2013) MiR-138 promotes the migration of cultured chicken embryonic hypothalamic cells by targeting reelin. Neuroscience 238:114–124. doi: 10.1016/j · DOI
  44. Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K, Wu M, Liang Y, Liu P, Tang J, Lu WH, Feng QS, Chen LZ, Qian CN, Bei JX, Kang T, Zeng Y-X (2012) MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle 11:2495–2506. doi: 10.4161/cc.20898 · DOI
  45. Wang W, Zhao LJ, Tan Y-X, Ren H, Qi ZT (2012) MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis 33:1113–1120. doi: 10.1093/carcin/bgs113 · DOI · Paper page
  46. Li JS, Yao ZX (2012) MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases. Mol Neurobiol 45:200–212. doi: 10.1007/s12035-011-8231-z · DOI

Cited by

Sorted by citations

See all 16

Metadata

Authors
Qian, B.-J., You, L., Shang, F.-F., Liu, J., Dai, P., Lin, N., He, M., Liu, R., Zhang, Y., Xu, Y., Zhang, Y.-H., & Wang, T.-H.
Venue
Molecular Neurobiology
Publisher
Springer Science and Business Media LLC
Published
2014-05-31
Volume
51
Issue
2
Pages
437-447
ISSN
  • 0893-7648
  • 1559-1182
DOI
10.1007/s12035-014-8745-2
Cited by
16
References
1
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review